Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Ipsen

Market Cap 12.73B 14.71B 11.74B 10.98B 20.49B 1,402B 20.95B 139B 54.09B 679B 55.23B 54.04B 2,361B P/E Ratio 2026 *
14.3x
P/E Ratio 2027 * 14x
Enterprise Value 11.37B 13.14B 10.48B 9.81B 18.3B 1,252B 18.71B 125B 48.3B 606B 49.32B 48.26B 2,108B EV / Sales 2026 *
2.67x
EV / Sales 2027 * 2.35x
Free-Float
40.65%
Yield 2026 *
0.92%
Yield 2027 * 0.96%
1 day+1.42%
1 week+1.88%
Current month+0.45%
1 month-4.38%
3 months+0.70%
6 months+29.47%
Current year+32.18%
1 week 152.7
Extreme 152.7
159.2
1 month 148.7
Extreme 148.7
167.4
Current year 116
Extreme 116
173.5
1 year 100.2
Extreme 100.2
173.5
3 years 87.95
Extreme 87.95
173.5
5 years 77
Extreme 77
173.5
10 years 34.2
Extreme 34.2
173.5
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2020
Chief Executive Officer 57 31/12/2019
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 29/08/2005
Chairman 68 21/11/2010
Director/Board Member 69 31/05/2012
Date Insider Type Main position Quantity % Market Cap.
05-31Fiscal year

Chief Executive Officer

-26,583 0.0317%
05-26Sell

Chief Executive Officer

-1,000 0.0012%
02-24Sell

Chairman

3,800 0.0045%
Change 5-day change 1-year change 3-year change Capi.($)
+1.42%+1.88%+52.27%+41.97% 14.71B
-0.73%+5.34%+40.78%+154.77% 1,013B
+0.63%+6.83%+52.44%+49.05% 574B
-0.21%+3.60%+18.71%+62.79% 397B
+0.08%+4.97%+21.24%+15.95% 324B
+0.81%+0.14%+24.45%+14.73% 280B
+1.75%+4.37%+24.64%+33.09% 273B
-1.98%-0.14%+15.10%+54.38% 182B
-0.91%-1.30%-45.78%-48.78% 194B
-3.20%-5.82%+10.35%+55.50% 151B
Average -0.11%+2.63%+21.42%+43.35% 340.34B
Weighted average by Cap. -0.07%+3.98%+28.06%+69.85%

Financials

2026 *2027 *
Net sales 4.25B 4.91B 3.92B 3.67B 6.85B 468B 7B 46.59B 18.07B 227B 18.45B 18.05B 789B 4.41B 5.1B 4.07B 3.8B 7.1B 486B 7.26B 48.32B 18.74B 235B 19.13B 18.72B 818B
Net income 923M 1.07B 851M 796M 1.49B 102B 1.52B 10.11B 3.92B 49.21B 4B 3.92B 171B 916M 1.06B 844M 790M 1.47B 101B 1.51B 10.03B 3.89B 48.81B 3.97B 3.89B 170B
Net Debt -1.36B -1.57B -1.26B -1.17B -2.19B -150B -2.24B -14.92B -5.78B -72.6B -5.91B -5.78B -252B -2.37B -2.74B -2.19B -2.05B -3.82B -261B -3.9B -25.98B -10.07B -126B -10.29B -10.07B -440B
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
11/06/26 157.30 +1.42% 32,266
10/06/26 155.10 -1.77% 129,360
09/06/26 157.90 +0.06% 113,067
08/06/26 157.80 0.00% 118,590
05/06/26 157.80 +2.20% 122,859
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
155.10EUR
Average target price
159.25EUR
Spread / Average Target
+2.68%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!